MD Labs

07/23/2026

New Blog Post on Counterfeit Adderall. https://www.mdlabs.com/blog/what-md-labs-found-in-counterfeit-adderall

03/23/2026

March 24th is National Adverse Drug Reaction Awareness Day. Why would anyone tolerate “trial-and-error” prescribing anymore?
Get Tested!


https://www.mdlabs.com/blog/march-24th-2026-is-national-adverse-drug-reaction-awareness-day

09/20/2025

Keeping up with current trends in pain management pharmacology (and making friends) at the Pacific Spine and Pain Symposium in Las Vegas.

07/08/2025

A Deep Dive into Urine Drug Testing

Matthew Rutledge joins Podcast host Dr. Casey Grover, MD to discuss testing methodologies, detection capabilities, and emerging trends in substance use.

Listen to the Addiction Medicine Made Easy Podcast, where host Dr. Casey Grover discusses urine drug testing with Matthew Rutledge, Co-founder of MD Labs with Denis Grizelj.

03/04/2025

Best legal team in the clinical laboratory sphere. They understand the challenges laboratories face and advocate for patient care and laboratorians.

Robinson+Cole

01/29/2025

MD Labs and Owners Triumph in Lawsuit Dismissal
MD Labs and its owners, Matthew Rutledge and Denis Grizelj, today announced the successful dismissal of a qui tam lawsuit filed by serial qui tam relator, OMNI Health Care of Melbourne, FL. The United States District Court for the District of Massachusetts granted summary judgment in favor of MD Labs, Mr. Rutledge and Mr. Grizelj, dismissing all claims with prejudice.
https://www.mdlabs.com/blog/dismissal

Matthew Rutledge and Denis Grizelj, today announced the successful dismissal of a lawsuit filed by serial qui tam relator, OMNI Health Care of Melbourne, FL, solely owned by Dr. Craig Deligdish. The United States District Court for the District of Massachusetts granted summary judgment in favor of

12/24/2024

Wishing everyone happy, healthy holidays and a fantastic new year!

10/28/2024

Supreme Court Ruling May Offer Increased Protections for Pain Management Providers!

The recent Supreme Court decision overturning the Chevron doctrine may be a game changer for pain management prescribers. Federal agencies, like the DEA, may now have less power to broadly interpret laws like the Controlled Substances Act, giving providers more clarity and protection in their medical decisions. Explore how this ruling may impact your practice and patient care.

https://www.mdlabs.com/blog/chevron-overturned

10/25/2024

We’re live at the Texas Pain Society Conference!

Our specialists in Patient Monitoring and Pharmacogenetics are hosting a booth today and tomorrow at the Texas Pain Society Conference. Come by to chat with our team about how our personalized testing services can support your pain management practice.

10/24/2024

More than 75% of people have genetic variations that affect how they respond to medications, including opioids. Discover how PGx testing is revolutionizing pain management and helping doctors provide safer, more effective treatments. Check out our new blog post: https://www.rxight.com/news/pain-management